Pfizer Inc

NYSE: PFE
$29.25
-$0.03 (-0.1%)
Real Time Data Delayed 15 Min.

PFE Articles

The Dow is set to finish essentially flat Wednesday, with Disney and Caterpillar weighing on the index as Pfizer and McDonald's do the heavy lifting.
Disney, DowDuPont, Pfizer, and Cisco Systems led the Dow higher Monday.
IBM, Pfizer, Walmart, and Coca-Cola were among the leading gainers on the Dow index Friday.
3M, Pfizer, Caterpillar, and United Technologies posted the best gains among the Dow 30 stocks Tuesday.
Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.
24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly results this week.
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
JetBlue orders planes from Airbus, Pfizer to defer some drug price increases, Toyota launches car-sharing service in Hawaii, and other important business headlines.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was...
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a billion dollars to its venture capital arm.